Align Technology, Inc. (ALGN)
USD 152.83
(-0.91%)
USD 152.83
(-0.91%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -840.47 Million USD | -3.11% |
| 2022 | -815.14 Million USD | 18.22% |
| 2021 | -996.71 Million USD | -11.19% |
| 2020 | -896.39 Million USD | -76.82% |
| 2019 | -506.96 Million USD | 20.4% |
| 2018 | -636.89 Million USD | -41.69% |
| 2017 | -449.51 Million USD | -15.47% |
| 2016 | -389.27 Million USD | -132.11% |
| 2015 | -167.71 Million USD | 16.09% |
| 2014 | -199.87 Million USD | 17.73% |
| 2013 | -242.95 Million USD | 20.7% |
| 2012 | -306.38 Million USD | -27.3% |
| 2011 | -240.67 Million USD | 18.32% |
| 2010 | -294.66 Million USD | -76.99% |
| 2009 | -166.48 Million USD | -91.14% |
| 2008 | -87.1 Million USD | 2.27% |
| 2007 | -89.11 Million USD | -104.34% |
| 2006 | -43.61 Million USD | 41.24% |
| 2005 | -74.21 Million USD | -9.49% |
| 2004 | -67.78 Million USD | -64.92% |
| 2003 | -41.1 Million USD | -39.17% |
| 2002 | -29.53 Million USD | 39.84% |
| 2001 | -49.08 Million USD | -5189.55% |
| 2000 | -928 Thousand USD | 86.4% |
| 1999 | -6.82 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -632.33 Million USD | 14.48% |
| 2024 Q3 | -945.5 Million USD | -44.6% |
| 2024 Q1 | -739.38 Million USD | 12.03% |
| 2023 Q1 | -733.38 Million USD | 10.03% |
| 2023 FY | -840.47 Million USD | -3.11% |
| 2023 Q4 | -840.47 Million USD | 26.31% |
| 2023 Q2 | -847.3 Million USD | -15.53% |
| 2023 Q3 | -1.14 Billion USD | -34.6% |
| 2022 Q3 | -923.65 Million USD | -22.41% |
| 2022 Q4 | -815.14 Million USD | 11.75% |
| 2022 FY | -815.14 Million USD | 18.22% |
| 2022 Q1 | -795.89 Million USD | 20.15% |
| 2022 Q2 | -754.55 Million USD | 5.19% |
| 2021 Q3 | -1.16 Billion USD | -14.95% |
| 2021 Q4 | -996.71 Million USD | 14.33% |
| 2021 FY | -996.71 Million USD | -11.19% |
| 2021 Q2 | -1.01 Billion USD | 5.21% |
| 2021 Q1 | -1.06 Billion USD | -19.13% |
| 2020 Q4 | -896.39 Million USD | -62.98% |
| 2020 FY | -896.39 Million USD | -76.82% |
| 2020 Q1 | -736.95 Million USD | -45.37% |
| 2020 Q2 | -353.74 Million USD | 52.0% |
| 2020 Q3 | -550.01 Million USD | -55.49% |
| 2019 Q1 | -472.59 Million USD | 25.8% |
| 2019 FY | -506.96 Million USD | 20.4% |
| 2019 Q4 | -506.96 Million USD | -13.42% |
| 2019 Q3 | -446.99 Million USD | -22.68% |
| 2019 Q2 | -364.36 Million USD | 22.9% |
| 2018 Q3 | -420.86 Million USD | 23.2% |
| 2018 FY | -636.89 Million USD | -41.69% |
| 2018 Q2 | -547.99 Million USD | -10.04% |
| 2018 Q1 | -498 Million USD | -10.79% |
| 2018 Q4 | -636.89 Million USD | -51.33% |
| 2017 Q1 | -261.02 Million USD | 32.95% |
| 2017 Q2 | -358.18 Million USD | -37.22% |
| 2017 Q4 | -449.51 Million USD | -23.96% |
| 2017 Q3 | -362.61 Million USD | -1.24% |
| 2017 FY | -449.51 Million USD | -15.47% |
| 2016 Q3 | -419.94 Million USD | -150.41% |
| 2016 FY | -389.27 Million USD | -132.11% |
| 2016 Q2 | -167.7 Million USD | -8.61% |
| 2016 Q4 | -389.27 Million USD | 7.3% |
| 2016 Q1 | -154.41 Million USD | 7.93% |
| 2015 FY | -167.71 Million USD | 16.09% |
| 2015 Q1 | -189.97 Million USD | 4.95% |
| 2015 Q2 | -161.75 Million USD | 14.86% |
| 2015 Q3 | -174.04 Million USD | -7.6% |
| 2015 Q4 | -167.71 Million USD | 3.63% |
| 2014 Q2 | -167.47 Million USD | 8.37% |
| 2014 Q3 | -180.67 Million USD | -7.88% |
| 2014 Q4 | -199.87 Million USD | -10.62% |
| 2014 FY | -199.87 Million USD | 17.73% |
| 2014 Q1 | -182.76 Million USD | 24.77% |
| 2013 Q2 | -164.49 Million USD | 49.96% |
| 2013 Q3 | -175.83 Million USD | -6.89% |
| 2013 Q4 | -242.95 Million USD | -38.17% |
| 2013 FY | -242.95 Million USD | 20.7% |
| 2013 Q1 | -328.74 Million USD | -7.3% |
| 2012 Q2 | -262.79 Million USD | -17.13% |
| 2012 Q1 | -224.36 Million USD | 6.78% |
| 2012 Q4 | -306.38 Million USD | -0.49% |
| 2012 FY | -306.38 Million USD | -27.3% |
| 2012 Q3 | -304.9 Million USD | -16.02% |
| 2011 Q2 | -168.6 Million USD | 45.37% |
| 2011 FY | -240.67 Million USD | 18.32% |
| 2011 Q3 | -202.22 Million USD | -19.94% |
| 2011 Q4 | -240.67 Million USD | -19.01% |
| 2011 Q1 | -308.6 Million USD | -4.73% |
| 2010 FY | -294.66 Million USD | -76.99% |
| 2010 Q4 | -294.66 Million USD | -11.23% |
| 2010 Q1 | -190.4 Million USD | -6.98% |
| 2010 Q3 | -264.92 Million USD | -12.35% |
| 2010 Q2 | -235.8 Million USD | -23.84% |
| 2009 Q3 | -135.96 Million USD | -11.28% |
| 2009 Q2 | -122.18 Million USD | -25.89% |
| 2009 Q1 | -97.05 Million USD | -11.42% |
| 2009 FY | -166.48 Million USD | -91.14% |
| 2009 Q4 | -177.98 Million USD | -30.91% |
| 2008 Q1 | -113.68 Million USD | -27.56% |
| 2008 Q3 | -79.75 Million USD | -23.96% |
| 2008 Q2 | -64.33 Million USD | 43.4% |
| 2008 FY | -87.1 Million USD | 2.27% |
| 2008 Q4 | -87.1 Million USD | -9.21% |
| 2007 Q3 | -87.96 Million USD | -34.11% |
| 2007 Q4 | -89.11 Million USD | -1.31% |
| 2007 Q1 | -48.2 Million USD | -10.54% |
| 2007 Q2 | -65.59 Million USD | -36.06% |
| 2007 FY | -89.11 Million USD | -104.34% |
| 2006 Q1 | -71.78 Million USD | 3.28% |
| 2006 Q3 | -59.03 Million USD | -2.69% |
| 2006 Q2 | -57.48 Million USD | 19.92% |
| 2006 Q4 | -43.61 Million USD | 26.12% |
| 2006 FY | -43.61 Million USD | 41.24% |
| 2005 Q4 | -74.21 Million USD | 3.53% |
| 2005 FY | -74.21 Million USD | -9.49% |
| 2005 Q1 | -67.63 Million USD | 0.22% |
| 2005 Q2 | -72.16 Million USD | -6.69% |
| 2005 Q3 | -76.93 Million USD | -6.61% |
| 2004 FY | -67.78 Million USD | -64.92% |
| 2004 Q1 | -44.47 Million USD | -8.21% |
| 2004 Q2 | -53.25 Million USD | -19.74% |
| 2004 Q3 | -60.85 Million USD | -14.27% |
| 2004 Q4 | -67.78 Million USD | -11.39% |
| 2003 Q4 | -41.1 Million USD | -25.07% |
| 2003 Q1 | -28.51 Million USD | 3.43% |
| 2003 Q2 | -26.78 Million USD | 6.09% |
| 2003 Q3 | -32.86 Million USD | -22.71% |
| 2003 FY | -41.1 Million USD | -39.17% |
| 2002 Q1 | -35.31 Million USD | 28.05% |
| 2002 Q4 | -29.53 Million USD | -83.41% |
| 2002 Q3 | -16.1 Million USD | 38.88% |
| 2002 Q2 | -26.34 Million USD | 25.41% |
| 2002 FY | -29.53 Million USD | 39.84% |
| 2001 Q2 | -37.8 Million USD | 31.03% |
| 2001 Q3 | -63.81 Million USD | -68.79% |
| 2001 Q4 | -49.08 Million USD | 23.08% |
| 2001 FY | -49.08 Million USD | -5189.55% |
| 2001 Q1 | -54.81 Million USD | 0.0% |
| 2000 FY | -928 Thousand USD | 86.4% |
| 1999 FY | -6.82 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 3203.427% |
| BrainsWay Ltd. | -10.32 Million USD | -8044.089% |
| Cerus Corporation | 84.35 Million USD | 1096.384% |
| Envoy Medical, Inc. | -3.81 Million USD | -21936.445% |
| electroCore, Inc. | -9.95 Million USD | -8342.692% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -16299.415% |
| IceCure Medical Ltd | -9.93 Million USD | -8360.54% |
| Inogen, Inc. | -103.56 Million USD | -711.507% |
| OrthoPediatrics Corp. | -9.26 Million USD | -8969.494% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -22983.494% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -6317.253% |
| MaxCyte, Inc. | -27.76 Million USD | -2927.303% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -16257.625% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -145873.979% |
| Orthofix Medical Inc. | 96.44 Million USD | 971.477% |
| PAVmed Inc | 29.08 Million USD | 2989.603% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -4861.745% |
| RxSight, Inc. | -6.68 Million USD | -12481.886% |
| Sight Sciences, Inc. | -102.71 Million USD | -718.254% |
| SI-BONE, Inc. | 5.72 Million USD | 14790.963% |
| TELA Bio, Inc. | -3.94 Million USD | -21183.11% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 1566.251% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 238869.886% |
| Acutus Medical, Inc. | 12.27 Million USD | 6944.776% |
| Talis Biomedical Corporation | -57.06 Million USD | -1372.855% |
| Spectral AI, Inc. | -3.5 Million USD | -23906.57% |
| Nano-X Imaging Ltd. | -48.02 Million USD | -1649.995% |
| CVRx, Inc. | -59.95 Million USD | -1301.811% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 42459.303% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 65883.161% |
| Bioventus Inc. | 372.51 Million USD | 325.622% |
| Venus Concept Inc. | 74.3 Million USD | 1231.169% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -8154.469% |
| LivaNova PLC | 62.53 Million USD | 1444.064% |
| 908 Devices Inc. | -115.09 Million USD | -630.234% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 362.066% |
| Nemaura Medical Inc. | 9.92 Million USD | 8568.198% |
| NeuroPace, Inc. | 54.33 Million USD | 1646.773% |
| LENSAR, Inc. | -18.31 Million USD | -4489.723% |
| Apyx Medical Corporation | -5.15 Million USD | -16216.638% |
| Cutera, Inc. | 288.3 Million USD | 391.526% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 11283.899% |
| BioSig Technologies, Inc. | 262 Thousand USD | 320890.076% |
| Anika Therapeutics, Inc. | -43.83 Million USD | -1817.568% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -9036.537% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 159.808% |
| Axonics, Inc. | -77.19 Million USD | -988.776% |
| Outset Medical, Inc. | 67.67 Million USD | 1341.848% |
| IRIDEX Corporation | -4.28 Million USD | -19500.513% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | -372.126% |
| IRadimed Corporation | -47.71 Million USD | -1661.284% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -27674.95% |
| INVO Bioscience, Inc. | 8.45 Million USD | 10045.052% |
| Telesis Bio, Inc. | 32.63 Million USD | 2675.364% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -33490.154% |
| Varex Imaging Corporation | 316.9 Million USD | 365.216% |
| Quipt Home Medical Corp. | 81.73 Million USD | 1128.293% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -30110.999% |
| Pulmonx Corporation | -42.36 Million USD | -1884.112% |
| Dynatronics Corporation | 6.2 Million USD | 13647.156% |
| Modular Medical, Inc. | -8.04 Million USD | -10351.007% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -19459.46% |
| Semler Scientific, Inc. | -57.13 Million USD | -1371.154% |
| InMode Ltd. | -135.39 Million USD | -520.759% |
| Bruker Corporation | 891.3 Million USD | 194.297% |
| Cytosorbents Corporation | 4.18 Million USD | 20197.25% |
| DexCom, Inc. | 2.02 Billion USD | 141.449% |
| Viveve Medical, Inc. | -13.81 Million USD | -5984.63% |
| ZimVie Inc. | 450.41 Million USD | 286.597% |
| Movano Inc. | -5.86 Million USD | -14227.821% |
| Cytek Biosciences, Inc. | -134.45 Million USD | -525.089% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -145873.979% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 42459.303% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 335.558% |
| Profound Medical Corp. | -18.17 Million USD | -4523.425% |
| Insulet Corporation | 798.1 Million USD | 205.309% |
| enVVeno Medical Corporation | -2.21 Million USD | -37793.147% |
| Surmodics, Inc. | -12.01 Million USD | -6895.755% |
| iCAD, Inc. | -21.2 Million USD | -3862.799% |
| Nuwellis, Inc. | -2.81 Million USD | -29714.473% |
| Biotricity, Inc. | 23.09 Million USD | 3739.544% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 997.449% |
| Aethlon Medical, Inc. | -4.5 Million USD | -18570.216% |
| InspireMD, Inc. | -8.04 Million USD | -10347.11% |
| PAVmed Inc. | 29.08 Million USD | 2989.603% |
| BIOLASE, Inc. | 11.34 Million USD | 7508.939% |
| Beyond Air, Inc. | 6.22 Million USD | 13592.856% |
| FONAR Corporation | -14.66 Million USD | -5631.002% |
| AxoGen, Inc. | 32.26 Million USD | 2704.816% |
| Vivani Medical, Inc. | 42 Thousand USD | 2001219.048% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -7785.813% |
| Inari Medical, Inc. | -7.16 Million USD | -11636.767% |
| UFP Technologies, Inc. | 40.77 Million USD | 2161.289% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 27489.149% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -17515.078% |
| Tenon Medical, Inc. | -1.25 Million USD | -66869.721% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -10950.092% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -6947.192% |
| AdaptHealth Corp. | 2.21 Billion USD | 137.901% |
| Sintx Technologies, Inc. | 905 Thousand USD | 92969.613% |
| NanoVibronix, Inc. | -3.27 Million USD | -25539.719% |
| Quanterix Corporation | -132.95 Million USD | -532.132% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -30110.999% |
| Sensus Healthcare, Inc. | -22.36 Million USD | -3657.97% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 211.51% |
| TransMedics Group, Inc. | 121.13 Million USD | 793.835% |
| ReWalk Robotics Ltd. | -26.18 Million USD | -3110.351% |
| NeuroMetrix, Inc. | -1.49 Million USD | -56266.904% |
| Hyperfine, Inc. | -75.61 Million USD | -1011.453% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 652.254% |
| Biomerica, Inc. | -3.38 Million USD | -24729.247% |
| Bone Biologics Corporation | -3.02 Million USD | -27669.729% |
| AVITA Medical, Inc. | -26.23 Million USD | -3104.034% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -45617.198% |
| Silk Road Medical, Inc | 64.42 Million USD | 1404.612% |